89 Recruiting Atopic Dermatitis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Atopic Dermatitis
Related Conditions
Top Recruiting Atopic Dermatitis Studies
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
📍 Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology — Birmingham, Alabama
View Study & Checklist ➔ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
📍 Aclaris Clinical Site — Phoenix, Arizona
View Study & Checklist ➔A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 Enveda Investigative Site — Encinitas, California
View Study & Checklist ➔This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
📍 Cahaba Dermatology & Skin Health Center- Site Number : 8400006 — Birmingham, Alabama
View Study & Checklist ➔Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
📍 UCLA Division of Dermatology — Los Angeles, California
View Study & Checklist ➔A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔A Study of Barzolvolimab in Patients With Atopic Dermatitis
📍 Cahaba Dermatology & Skin Health Center, LLC — Birmingham, Alabama
View Study & Checklist ➔Molecular Signatures of Cutaneous Dupilumab Response
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
📍 Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
📍 Kymera Investigative Site — Birmingham, Alabama
View Study & Checklist ➔Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
📍 Novartis Investigative Site — Birmingham, Alabama
View Study & Checklist ➔A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
📍 AllerVie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔A Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
📍 Inmagene Site 1 — Lancaster, California
View Study & Checklist ➔Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
📍 University of California, San Diego: Dermatology Clinical Trials Unit — San Diego, California
View Study & Checklist ➔A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
📍 First OC Dermatology — Irvine, California
View Study & Checklist ➔Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
📍 Pfizer — New York, New York
View Study & Checklist ➔A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
📍 The Center for Dermatology Clinical Research — Fremont, California
View Study & Checklist ➔Ethnic Differences in Mechanisms of Action of Dupilumab
📍 University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
📍 Investigational Site — Darlinghurst, New South Wales
View Study & Checklist ➔Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 First OC Dermatology — Fountain Valley, California
View Study & Checklist ➔Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
View Study & Checklist ➔Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
📍 Corvus Clinical Trials — South San Francisco, California
View Study & Checklist ➔A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
📍 Arkansas Research Trials — North Little Rock, Arkansas
View Study & Checklist ➔A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
📍 Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 — Fountain Hills, Arizona
View Study & Checklist ➔Dupilumab De-escalation in Pediatric Atopic Dermatitis
📍 Johns Hopkins Univerisity — Baltimore, Maryland
View Study & Checklist ➔Opzelura Experience Study
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
View Study & Checklist ➔A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
📍 Clinical Research Center of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
📍 Allervie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔Virtual Reality for Pain Management During Dupilumab Injection
📍 St. Justine's Hospital — Montreal, Quebec
View Study & Checklist ➔Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
📍 Allergy and Asthma Medical Group and Research Center — San Diego, California
View Study & Checklist ➔A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
📍 Atd002 52021 — Oceanside, California
View Study & Checklist ➔A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
📍 Vital Prospects Clinical Research Institute., PC — Tulsa, Oklahoma
View Study & Checklist ➔Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
📍 Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut
View Study & Checklist ➔Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
📍 Cahaba Dermatology Skin Health Center — Birmingham, Alabama
View Study & Checklist ➔A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
📍 AllerVie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
📍 Marvel Clinical Research — Huntington Beach, California
View Study & Checklist ➔